These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 22552811)
41. "Omics" of HER2-positive breast cancer. Bravatà V; Cammarata FP; Forte GI; Minafra L OMICS; 2013 Mar; 17(3):119-29. PubMed ID: 23421906 [TBL] [Abstract][Full Text] [Related]
42. Lasp1 is down-regulated in NMDA receptor antagonist-treated mice and implicated in human schizophrenia susceptibility. Joo J; Lee S; Nah SS; Kim YO; Kim DS; Shim SH; Hwangbo Y; Kim HK; Kwon JT; Kim JW; Song HY; Kim HJ J Psychiatr Res; 2013 Jan; 47(1):105-12. PubMed ID: 23040864 [TBL] [Abstract][Full Text] [Related]
43. LASP1 in Tumor and Tumor Microenvironment. Hu Z; Wang X; Cui Y; Li C; Wang S Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505 [TBL] [Abstract][Full Text] [Related]
44. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. Frietsch JJ; Grunewald TG; Jasper S; Kammerer U; Herterich S; Kapp M; Honig A; Butt E Br J Cancer; 2010 May; 102(11):1645-53. PubMed ID: 20461080 [TBL] [Abstract][Full Text] [Related]
45. Moonlight human ribosomal protein L13a downregulation is associated with p53 and HER2/neu expression in breast cancer. Molavi G; Samadi N; Hashemzadeh S; Halimi M; Hosseingholi EZ J Appl Biomed; 2020 Aug; 18(2-3):46-53. PubMed ID: 34907725 [TBL] [Abstract][Full Text] [Related]
46. LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator. Butt E; Howard CM; Raman D Cells; 2022 Nov; 11(23):. PubMed ID: 36497077 [TBL] [Abstract][Full Text] [Related]
47. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein. Orth MF; Cazes A; Butt E; Grunewald TG Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104 [TBL] [Abstract][Full Text] [Related]
48. Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer. Rey-Vargas L; Bejarano-Rivera LM; Mejia-Henao JC; Sua LF; Bastidas-Andrade JF; Ossa CA; Gutiérrez-Castañeda LD; Fejerman L; Sanabria-Salas MC; Serrano-Gómez SJ Front Oncol; 2022; 12():989761. PubMed ID: 36620598 [TBL] [Abstract][Full Text] [Related]
49. Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies. Cangiano J; Centeno BA; Garrett CR; Cáceres W; de Jesús A; Lee JH; Pavía O; Jove R; Báez L; Sullivan DM; Muro-Cacho CA; Muñoz-Antonia T Dig Dis Sci; 2008 Aug; 53(8):2090-100. PubMed ID: 18224443 [TBL] [Abstract][Full Text] [Related]
50. Activating mutations in HER2: neu opportunities and neu challenges. Weigelt B; Reis-Filho JS Cancer Discov; 2013 Feb; 3(2):145-7. PubMed ID: 23400474 [TBL] [Abstract][Full Text] [Related]
51. Beta class II tubulin predominates in normal and tumor breast tissues. Dozier JH; Hiser L; Davis JA; Thomas NS; Tucci MA; Benghuzzi HA; Frankfurter A; Correia JJ; Lobert S Breast Cancer Res; 2003; 5(5):R157-69. PubMed ID: 12927047 [TBL] [Abstract][Full Text] [Related]
52. Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules. Pradip D; Bouzyk M; Dey N; Leyland-Jones B Am J Cancer Res; 2013; 3(2):173-95. PubMed ID: 23593540 [TBL] [Abstract][Full Text] [Related]
53. Validation of analytical breast cancer microarray analysis in medical laboratory. Darweesh AS; Louka ML; Hana M; Rashad S; El-Shinawi M; Sharaf-Eldin A; Kassim SK Med Oncol; 2014 Oct; 31(10):201. PubMed ID: 25182704 [TBL] [Abstract][Full Text] [Related]
54. Paving the path for invasion: The polyedric role of LASP1 in cancer. Ruggieri V; Agriesti F; Tataranni T; Perris R; Mangieri D Tumour Biol; 2017 Jun; 39(6):1010428317705757. PubMed ID: 28621232 [TBL] [Abstract][Full Text] [Related]
55. Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours. Tai LK; Zhang DH; Wong LL; Koay ES Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S17-8. PubMed ID: 15651188 [No Abstract] [Full Text] [Related]
56. Association study of Bif-1 gene expression with histopathological characteristics and hormone receptors in breast cancer. Mohammadi K; Salimi M; Angaji SA; Saniotis A; Mahjoobi F BMC Womens Health; 2022 Nov; 22(1):471. PubMed ID: 36434659 [TBL] [Abstract][Full Text] [Related]
57. Investigation of the GRB2, GRB7, and CSH1 genes as candidates for the Silver-Russell syndrome (SRS) on chromosome 17q. Hitchins MP; Abu-Amero S; Apostolidou S; Monk D; Stanier P; Preece MA; Moore GE J Med Genet; 2002 Mar; 39(3):E13. PubMed ID: 11897833 [No Abstract] [Full Text] [Related]
58. Grb-ing hold of insulin signaling. Ceccarelli DF; Sicheri F Nat Struct Mol Biol; 2009 Aug; 16(8):803-4. PubMed ID: 19654617 [No Abstract] [Full Text] [Related]
59. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration. Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588 [TBL] [Abstract][Full Text] [Related]